Assenagon Asset Management
ROIV icon

Assenagon Asset Management’s Roivant Sciences ROIV Stock Holding History

Assenagon Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296M Buy
8,362,952
+1,286,464
+18% +$38M 0.37% 44
2026
Q1 		$196M Buy
7,076,488
+139,376
+2% +$3.58M 0.3% 58
2025
Q4 		$151M Buy
6,937,112
+6,877,348
+11,508% +$136M 0.21% 87
2025
Q3 		$904K Buy
59,764
+2,731
+5% +$33.8K ﹤0.01% 955
2025
Q2 		$643K Buy
57,033
+496
+0.9% +$5.38K ﹤0.01% 997
2025
Q1 		$570K Buy
+56,537
New +$611K ﹤0.01% 995
2024
Q2 		– Sell
-1,018,899
Closed -$10.7M – 1483
2024
Q1 		$10.7M Sell
1,018,899
-44,493
-4% -$480K 0.03% 408
2023
Q4 		$11.9M Buy
1,063,392
+703,830
+196% +$6.86M 0.03% 413
2023
Q3 		$4.2M Buy
+359,562
New +$4.06M 0.01% 622

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Assenagon Asset Management's ROIV Position: Q2 2026 in Review

Assenagon Asset Management increased its Roivant Sciences (ROIV) stake by 18% in Q2 2026, buying an estimated $38M and bringing the position to 8,362,952 shares worth $296M. The position accounts for 0.37% of the portfolio, ranked #44.

Assenagon Asset Management first reported a position in ROIV in Q3 2023 and has held it in 9 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Assenagon Asset Management held 8,362,952 shares of Roivant Sciences worth $296M as of Q2 2026.
  • Assenagon Asset Management bought 1,286,464 Roivant Sciences shares in Q2 2026, an estimated $38M.
  • Roivant Sciences made up 0.37% of Assenagon Asset Management's portfolio in Q2 2026, its #44 holding.
  • Assenagon Asset Management first reported a position in Roivant Sciences in Q3 2023 and has held it in 9 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.